Use of Recombinant Human Erythropoietin in Renal Anemia in Children
DOI:
https://doi.org/10.3329/bsmmuj.v2i1.3713Keywords:
Erythropoietin is a hormone highly effective as like as natural erythropoietin to maintain target hemoglobin and hematocrit level in renal anemia. Its advantage over blood transfusion has been proved by improving the quality of life and decreasing morbidiAbstract
Erythropoietin is a hormone highly effective as like as natural erythropoietin to maintain target hemoglobin and hematocrit level in renal anemia. Its advantage over blood transfusion has been proved by improving the quality of life and decreasing morbidity and mortality in ESRD patients. Effectiveness of r-erythropoietin depends on absences of infection, inflammation and vitamin deficiency and iron status. Iron supplementation is needed before r-erythropoietin administration and sub-cutaneous rout is better in renal anemia because of slow and sustained releases of r-erythropoietin from the site of administration. Target hemoglobin level is 11-12.5 gm/dl and hematocrit is 33% which can be achieved by this hormone therapy.
Key words- Recombinant erythropoietin, renal anemia, end stage renal disease.
DOI: 10.3329/bsmmuj.v2i1.3713
BSMMU J 2009; 2(1): 50-53
Downloads
283
78
